published on 31 May 2018
Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role for pharmaceutical companies
published on 21 Feb 2018
How to accelerate pharmaceutical R&D: A new framework for sharing IP with global health researchers.
published on 23 Jan 2018
2018 Antimicrobial Resistance Benchmark
published on 02 Jan 2018
Increasing access to cancer care: how can we guide and track actions by pharmaceutical companies?
published on 01 Dec 2017
World AIDS Day 2017: Enabling broad access to best-in-class HIV treatment – Best practice for originators
published on 07 Nov 2017
Why it matters – Pharmaceutical Compliance, Anti-corruption and Access to Medicine
published on 12 Oct 2017
The Lancet: Can the Antimicrobial Resistance Benchmark blaze a new trail?
published on 05 Oct 2017
2017 Methodology for the 2018 Access to Medicine Index
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.